Crystal structure of hexaaquabis(μ2-3-(6-carboxylatopyridin-2-yl)-5-(pyrazin-2-yl)-1,2,4-triazol-1-ido)bis(μ3-3-(6-carboxylatopyridin-2-yl)5-(pyrazin-2-yl)-1,2,4-triazol-1-ido)tetra-manganese(II) dihydrate, C48H40Mn4N24O16

被引:0
|
作者
Wei Xue-Feng [2 ]
Miao Juan [2 ]
Shi Ling-Ling [1 ]
机构
[1] Chinese Res Inst Environm Sci, Beijing 100012, Peoples R China
[2] Henan Univ Sci & Technol, Chem Engn & Pharmaceut Coll, Luoyang 471003, Peoples R China
关键词
MAGNETIC-PROPERTIES; COMPLEXES;
D O I
10.1515/ncrs-2014-9097
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
C48H40Mn4N24O16, monoclinic, P2(1)/c (no. 14), a = 13.458(7) angstrom, b = 14.095(8) angstrom, c = 14.679(8) angstrom, b = 96.535(7)degrees, 2766(3) angstrom(3), Z = 2, R-gt(F) = 0.0570, wR(ref)(F-2) = 0.1273, T = 296 K.
引用
收藏
页码:375 / 377
页数:3
相关论文
共 50 条
  • [31] 3-Pyridin-2-yl-1H-1,2,4-triazol-5-amine
    Dolzhenko, Anton V.
    Tan, Geok Kheng
    Koh, Lip Lin
    Dolzhenko, Anna V.
    Chui, Wai Keung
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : O125 - U2337
  • [32] Diaquabis[5-(pyrazin-2-yl-kN(1))-3-(pyridin-3-yl)-1,2,4-triazolido-kappa N-1]-zinc
    Wang, Ye-Nan
    Dong, Wen-Wen
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2014, 70 : M116 - +
  • [33] STRUCTURE OF 2-[5-(2-PYRIDYL)-1H-1,2,4-TRIAZOL-3-YL]PYRIDINIUM PERCHLORATE
    PRINS, R
    BIRKER, PJMWL
    VERSCHOOR, GC
    ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1982, 38 (NOV): : 2934 - 2935
  • [34] Crystal structure of bis{3-(3,4-dimethoxyphenyl)-5-[6-(pyrazol-1-yl)pyridin-2-yl]-1,2,4-triazol-3-ato}-iron(II)-methanol-chloroform (1/2/2)
    Znovjyak, Kateryna
    Fritsky, Igor O.
    Sliva, Tatiana Y.
    Amirkhanov, Vladimir M.
    Malinkin, Sergey O.
    Shova, Sergiu
    Seredyuk, Maksym
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2023, 79 : 962 - +
  • [35] Diaquabis{5-(pyridin-2-yl-jN)-3-[4-(pyridin-4-yl)phenyl]-1H-1,2,4-triazol-1-ido-kappa N-1}cobalt(II)
    Li, Bin
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : M141 - +
  • [36] Diaquabis{5-(pyridin-2-yl-kappa N)-3-[4-(pyridin- 4-yl) phenyl]-1H-1,2,4-triazol-1-ido-kappa N' 1} zinc
    Li, Bin
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : M214 - +
  • [37] Crystal structure of bis{3-(3-bromo-4-methoxyphenyl)-5-[6-(1H-pyrazol-1-yl)pyridin-2-yl]-1,2,4-triazol-3-ato}iron(II) methanol disolvate
    Znovjyak, Kateryna
    Fritsky, Igor O.
    Sliva, Tatiana Y.
    Amirkhanov, Vladimir M.
    Malinkin, Sergey O.
    Shova, Sergiu
    Seredyuk, Maksym
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2022, 78 : 1138 - +
  • [38] Discovery of 1-(4-(5-(5-amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl) pyrazin-2-yl)-1-ethyl-1,2,4-triazol-3-yl) piperidin-1-yl)-3-hydroxypropan-1-one (AZD8835): A potent and selective inhibitor of PI3Kα and PI3Kδ for the treatment of cancers
    Barlaam, Bernard
    Cosulich, Sabina
    Delouvrie, Bebedicte
    Ellston, Rebecca
    Fitzek, Martina
    Germain, Herve
    Green, Stephen
    Hancox, Urs
    Harris, Craig S.
    Hudson, Kevin
    Lambert-van der Brempt, Christine
    Lebraud, Honorine
    Magnien, Franoise
    Lamorlette, Maryannick
    Le Griffon, Antoine
    Morgentin, Remy
    Ouvry, Gilles
    Page, Ken
    Pasquet, Georges
    Polanska, Urszula
    Ruston, Linette
    Saleh, Twana
    Vautier, Michel
    Ward, Lara
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (22) : 5155 - 5162
  • [39] 2-{[5-(Adamantan-1-yl)-4-methyl-4H-1,2,4-triazol-3-yl]sulfanyl}-N,N-dimethylethanamine
    El-Emam, Ali A.
    Lahsasni, Siham
    Asiri, Hanadi H.
    Quah, Ching Kheng
    Fun, Hoong-Kun
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1356 - +
  • [40] Diaquabis{3-[4-(1H-imidazol-1-yl)-phenyl]-5-(pyridin-2-yl-kappa N)-1H-1,2,4triazol-1-ido-kappa N-1}zinc
    Wang, You -Song
    Qiu, Guang-Mei
    Wang, Cui-Juan
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : M1182 - +